0001104659-18-051627.txt : 20180813
0001104659-18-051627.hdr.sgml : 20180813
20180813211519
ACCESSION NUMBER: 0001104659-18-051627
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180803
FILED AS OF DATE: 20180813
DATE AS OF CHANGE: 20180813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhen Marianne
CENTRAL INDEX KEY: 0001750085
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 181014029
MAIL ADDRESS:
STREET 1: C/O INNOVIVA, INC.
STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Innoviva, Inc.
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 6502389600
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY
STREET 2: SUITE 500
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: THERAVANCE INC
DATE OF NAME CHANGE: 20020207
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
3
1
a3.xml
3
X0206
3
2018-08-03
0
0001080014
Innoviva, Inc.
INVA
0001750085
Zhen Marianne
2000 SIERRA POINT PARKWAY
SUITE 500
BRISBANE
CA
94005
0
1
0
0
Chief Accounting Officer
Common Stock
24104
D
Includes 18,257 shares of common stock granted pursuant to time-based restricted stock awards (RSAs). The RSAs provide that 25% of the shares underlying any grant vests approximately one year following grant and 6.25% of the shares underlying the grant vest quarterly thereafter on the Issuer's standard vesting dates, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
/s/ Marianne Zhen
2018-08-13